DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MKC-1
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MKC-1
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY3023414
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY3023414
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TNT-1B
2
Antibody
Investigational
Unknown
Unknown
Glioblastoma
DNA-histone H1 complex binding agent
TNT-1B
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRX-03140
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Serotonin 4 (5-HT4) receptor partial agonist
PRX-03140
×
Maximum Phase:
2
First Approval:
None
UNII:
7QGN8QXG7I
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O3S
Molecular Weight:
377.51
AlogP:
2.96
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NI-0801
2
Antibody
Investigational
Unknown
Unknown
Dermatitis, Allergic Contact; Liver Cirrhosis, Biliary
C-X-C motif chemokine 10 inhibitor
NI-0801
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RALFINAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia; Pain
Glutamate [NMDA] receptor antagonist
RALFINAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3LPF0S0GVV
Molecule Type:
Small molecule
Molecular Formula:
C17H19FN2O2
Molecular Weight:
302.35
AlogP:
2.37
PSA:
64.35
HBD:
2.0
HBA:
#RotB:
7.0
Source:
VESNARINONE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
VESNARINONE
×
Maximum Phase:
2
First Approval:
None
UNII:
5COW40EV8M
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3O4
Molecular Weight:
395.46
AlogP:
2.55
PSA:
71.11
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PABINAFUSP ALFA
2
Protein
Investigational
Unknown
Unknown
Mucopolysaccharidoses
Dermatan sulfate hydrolytic enzyme
PABINAFUSP ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
TRF8S0U6ON
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APITEGROMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Growth/differentiation factor 8 inhibitor
APITEGROMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
UZ54216N0Y
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3016859
2
Unknown
Investigational
Unknown
Unknown
Diabetic Nephropathies; Low Back Pain; Neuralgia; Osteoarthritis
Proepiregulin inhibitor
LY-3016859
×
Maximum Phase:
2
First Approval:
None
UNII:
FP2PL0HRK8
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E-6201
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Psoriasis
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
E-6201
×
Maximum Phase:
2
First Approval:
None
UNII:
CZP9GB25HO
Molecule Type:
Small molecule
Molecular Formula:
C21H27NO6
Molecular Weight:
389.45
AlogP:
2.27
PSA:
116.09
HBD:
4.0
HBA:
#RotB:
2.0
Source:
PYRIDOXAL PHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Movement Disorders
Unknown
PYRIDOXAL PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
F06SGE49M6
Molecule Type:
Small molecule
Molecular Formula:
C8H12NO7P
Molecular Weight:
265.16
AlogP:
0.52
PSA:
116.95
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BISOCTRIZOLE
2
Small molecule
Investigational
Unknown
Unknown
Urticaria
Sunscreen
BISOCTRIZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8NT850T0YS
Molecule Type:
Small molecule
Molecular Formula:
C41H50N6O2
Molecular Weight:
658.89
AlogP:
9.58
PSA:
101.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
LUVADAXISTAT
2
Small molecule
Investigational
Unknown
Unknown
Friedreich Ataxia; Schizophrenia
Unknown
LUVADAXISTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
76IC00YRVR
Molecule Type:
Small molecule
Molecular Formula:
C13H11F3N2O2
Molecular Weight:
284.24
AlogP:
2.28
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CLEMIZOLE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Carcinoma, Hepatocellular; Epilepsies, Myoclonic
Unknown
CLEMIZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
T97CB3796L
Molecule Type:
Small molecule
Molecular Formula:
C19H20ClN3
Molecular Weight:
325.84
AlogP:
4.33
PSA:
21.06
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LICOGLIFLOZIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Kidney Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polycystic Ovary Syndrome
Sodium/glucose cotransporter 1 inhibitor
LICOGLIFLOZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
57J06X6EI0
Molecule Type:
Small molecule
Molecular Formula:
C23H28O7
Molecular Weight:
416.47
AlogP:
1.13
PSA:
108.61
HBD:
4.0
HBA:
#RotB:
5.0
Source:
IMPLITAPIDE
2
Small molecule
Investigational
Unknown
Unknown
Hyperlipoproteinemia Type II; Hypertriglyceridemia
Microsomal triglyceride transfer protein inhibitor
IMPLITAPIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Q70OH404HR
Molecule Type:
Small molecule
Molecular Formula:
C35H37N3O2
Molecular Weight:
531.7
AlogP:
6.98
PSA:
67.15
HBD:
2.0
HBA:
#RotB:
8.0
Source:
O-(2-FLUOROETHYL)-L-TYROSINE F-18
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
O-(2-FLUOROETHYL)-L-TYROSINE F-18
×
Maximum Phase:
2
First Approval:
None
UNII:
1326R5J1IA
Molecule Type:
Small molecule
Molecular Formula:
C11H14FNO3
Molecular Weight:
226.24
AlogP:
0.99
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SAMALIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Multiple Myeloma; Neoplasms
OX-2 membrane glycoprotein inhibitor
SAMALIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
64EUX713G6
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRC-6211
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
GRC-6211
×
Maximum Phase:
2
First Approval:
None
UNII:
4S841S9BO9
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MENAQUINONE 7
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MENAQUINONE 7
×
Maximum Phase:
2
First Approval:
None
UNII:
8427BML8NY
Molecule Type:
Small molecule
Molecular Formula:
C46H64O2
Molecular Weight:
649.02
AlogP:
14.1
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
20.0
Source:
FIRSOCOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Non-alcoholic Fatty Liver Disease
Acetyl-CoA carboxylase negative allosteric modulator
FIRSOCOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
XE10NJQ95M
Molecule Type:
Small molecule
Molecular Formula:
C28H31N3O8S
Molecular Weight:
569.64
AlogP:
3.95
PSA:
135.02
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ZSTK-474
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
ZSTK-474
×
Maximum Phase:
2
First Approval:
None
UNII:
K0068GK39A
Molecule Type:
Small molecule
Molecular Formula:
C23H17NOS
Molecular Weight:
355.46
AlogP:
6.25
PSA:
32.59
HBD:
1.0
HBA:
#RotB:
1.0
Source:
FAZA
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FAZA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLINVACIMAB
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Glioblastoma
Vascular endothelial growth factor receptor 2 inhibitor
OLINVACIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
VFH55IZ5VI
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOSWELLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Relapsing-Remitting
Unknown
BOSWELLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
B252M1YO2V
Molecule Type:
Small molecule
Molecular Formula:
C30H48O3
Molecular Weight:
456.71
AlogP:
7.09
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SER-100
2
Protein
Investigational
Unknown
Unknown
Hypertension
Unknown
SER-100
×
Maximum Phase:
2
First Approval:
None
UNII:
VJ98TJ922K
Molecule Type:
Protein
Molecular Formula:
C85H141N27O15
Molecular Weight:
1781.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PACTIMIBE
2
Small molecule
Investigational
Unknown
Unknown
Atherosclerosis; Coronary Disease
Unknown
PACTIMIBE
×
Maximum Phase:
2
First Approval:
None
UNII:
D874R9PZ9T
Molecule Type:
Small molecule
Molecular Formula:
C25H40N2O3
Molecular Weight:
416.61
AlogP:
5.64
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ZIMLOVISERTIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Hidradenitis Suppurativa; Severe Acute Respiratory Syndrome
Interleukin-1 receptor-associated kinase 4 inhibitor
ZIMLOVISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
S3F315JJXI
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.37
AlogP:
1.58
PSA:
103.54
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ISIS-463588
2
Unknown
Investigational
Unknown
Unknown
Obesity
Unknown
ISIS-463588
×
Maximum Phase:
2
First Approval:
None
UNII:
YJ4APB5MQC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SSR125543
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Adrenal Hyperplasia, Congenital
Corticotropin releasing factor receptor 1 antagonist
SSR125543
×
Maximum Phase:
2
First Approval:
None
UNII:
MFT24BX55I
Molecule Type:
Small molecule
Molecular Formula:
C27H28ClFN2OS
Molecular Weight:
483.05
AlogP:
7.52
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
8.0
Source:
STI-3031
2
Unknown
Investigational
Unknown
Unknown
Granuloma, Lethal Midline; Neoplasms
Unknown
STI-3031
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIVIFENE
2
Small molecule
Investigational
Unknown
Unknown
Lymphoproliferative Disorders; Sarcoma, Kaposi; Cervical Intraepithelial Neoplasia
Unknown
SIVIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
XAV05295I5
Molecule Type:
Small molecule
Molecular Formula:
C19H14N4O6
Molecular Weight:
394.34
AlogP:
3.78
PSA:
151.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
DERSALAZINE SODIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DERSALAZINE SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLECONARIL
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Sepsis; Virus Diseases
VP1 capsid protein disrupting agent
PLECONARIL
×
Maximum Phase:
2
First Approval:
None
UNII:
9H4570Q89D
Molecule Type:
Small molecule
Molecular Formula:
C18H18F3N3O3
Molecular Weight:
381.35
AlogP:
4.68
PSA:
74.18
HBD:
0.0
HBA:
#RotB:
6.0
Source:
1
2
…
147
148
149
150
151
152
153
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA